Abstract
PreOpNet is a novel deep-learning algorithm using 12-lead digital electrocardiogram (ECG) for preoperative risk assessment of all-cause death and major adverse cardiac events (MACE) within 30 days. Its performance in European high-risk patients undergoing major non-cardiac surgery-the target population for guideline-recommended risk assessment-and comparison to high-sensitivity cardiac troponin T (hs-cTnT), is unknown. In a prospective European study (2014-2019), 6098 high-risk patients with available ECGs were enrolled. PreOpNet showed moderate discrimination for death (AUC 0.707) and MACE (0.675), but overestimated risk. It outperformed the revised cardiac risk index (RCRI) for death (AUC 0.644), but not for MACE (0.662). Hs-cTnT remained superior for both outcomes (AUC 0.762 and 0.743). Importantly, PreOpNet provided incremental prognostic value when combined with RCRI and/or hs-cTnT. PreOpNet has limited benefit for preoperative risk stratification in high-risk surgical patients as a stand-alone test. However, it holds promise when used in conjunction with RCRI and hs-cTnT. Clinical Trial Registration: ClinicalTrials.gov number: NCT02573532; https://www.clinicaltrials.gov/study/NCT02573532 .